94 related articles for article (PubMed ID: 38573820)
1. The role of PALLD-STAT3 interaction in megakaryocyte differentiation and thrombocytopenia treatment.
Li G; Jiang H; Wang L; Liang T; Ding C; Yang M; Shen Y; Xin M; Zhang L; Dai J; Sun X; Chen X; Liu J; Xu Y
Haematologica; 2024 May; ():. PubMed ID: 38813732
[TBL] [Abstract][Full Text] [Related]
2. Daucosterol regulates JAK2-STAT3 signaling pathway to promote megakaryocyte differentiation.
Zhang Z; Shang G; Lu Z; Hu J; Liu H; Lu T; Lu X
Blood Cells Mol Dis; 2024 Jul; 107():102858. PubMed ID: 38796983
[TBL] [Abstract][Full Text] [Related]
3. Megakaryocyte modification of platelets in thrombocytopenia.
Roweth HG; Parvin S; Machlus KR
Curr Opin Hematol; 2018 Sep; 25(5):410-415. PubMed ID: 29985173
[TBL] [Abstract][Full Text] [Related]
4. Linkage between the mechanisms of thrombocytopenia and thrombopoiesis.
Eto K; Kunishima S
Blood; 2016 Mar; 127(10):1234-41. PubMed ID: 26787737
[TBL] [Abstract][Full Text] [Related]
5. Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.
Zhou L; Ni C; Liao R; Tang X; Yi T; Ran M; Huang M; Liao R; Zhou X; Qin D; Wang L; Huang F; Xie X; Wan Y; Luo J; Wang Y; Wu J
Elife; 2024 Apr; 13():. PubMed ID: 38573820
[TBL] [Abstract][Full Text] [Related]
6. Novel chemical-structure TPOR agonist, TMEA, promotes megakaryocytes differentiation and thrombopoiesis via mTOR and ERK signalings.
Jiang X; Sun Y; Yang S; Wu Y; Wang L; Zou W; Jiang N; Chen J; Han Y; Huang C; Wu A; Zhang C; Wu J
Phytomedicine; 2023 Feb; 110():154637. PubMed ID: 36610353
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin.
Wang L; Zhang T; Liu S; Mo Q; Jiang N; Chen Q; Yang J; Han YW; Chen JP; Huang FH; Li H; Zhou J; Luo JS; Wu JM
Pharmacol Res; 2022 Mar; 177():106096. PubMed ID: 35077844
[TBL] [Abstract][Full Text] [Related]
8. Vilazodone does not inhibit sexual behavior in male rats in contrast to paroxetine: A role for 5-HT1A receptors?
Oosting RS; Chan JSW; Olivier B; Banerjee P
Neuropharmacology; 2016 Aug; 107():271-277. PubMed ID: 27040795
[TBL] [Abstract][Full Text] [Related]
9. Alnustone promotes megakaryocyte differentiation and platelet production via the interleukin-17A/interleukin-17A receptor/Src/RAC1/MEK/ERK signaling pathway.
Li Y; Lai J; Ran M; Yi T; Zhou L; Luo J; Liu X; Tang X; Huang M; Xie X; Li H; Yang Y; Zou W; Wu J
Eur J Pharmacol; 2024 May; 971():176548. PubMed ID: 38570080
[TBL] [Abstract][Full Text] [Related]
10. Xanthotoxin, a novel inducer of platelet formation, promotes thrombocytopoiesis via IL-1R1 and MEK/ERK signaling.
Lai J; Li Y; Ran M; Huang Q; Huang F; Zhu L; Wu Y; Zou W; Xie X; Tang Y; Yang F; Wu A; Ge G; Wu J
Biomed Pharmacother; 2023 Jul; 163():114811. PubMed ID: 37156117
[TBL] [Abstract][Full Text] [Related]
11. An integrated approach of network pharmacology, molecular docking, and experimental verification uncovers kaempferol as the effective modulator of HSD17B1 for treatment of endometrial cancer.
Ruan GY; Ye LX; Lin JS; Lin HY; Yu LR; Wang CY; Mao XD; Zhang SH; Sun PM
J Transl Med; 2023 Mar; 21(1):204. PubMed ID: 36932403
[TBL] [Abstract][Full Text] [Related]
12. The combination of machine learning and transcriptomics reveals a novel megakaryopoiesis inducer, MO-A, that promotes thrombopoiesis by activating FGF1/FGFR1/PI3K/Akt/NF-κB signaling.
Zhang T; Mo Q; Jiang N; Wu Y; Yang X; Chen W; Li Q; Yang S; Yang J; Zeng J; Huang F; Huang Q; Luo J; Wu J; Wang L
Eur J Pharmacol; 2023 Apr; 944():175604. PubMed ID: 36804544
[TBL] [Abstract][Full Text] [Related]
13. Fibrin-glycoprotein VI interaction increases platelet procoagulant activity and impacts clot structure.
Gauer JS; Duval C; Xu RG; Macrae FL; McPherson HR; Tiede C; Tomlinson D; Watson SP; Ariëns RAS
J Thromb Haemost; 2023 Mar; 21(3):667-681. PubMed ID: 36696196
[TBL] [Abstract][Full Text] [Related]
14. Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia.
Wang L; Liu S; Luo J; Mo Q; Ran M; Zhang T; Li X; Zou W; Mei Q; Chen J; Yang J; Zeng J; Huang F; Wu A; Zhang C; Wu J
Haematologica; 2023 May; 108(5):1394-1411. PubMed ID: 36546424
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a pyrano[2,3-b]pyridine derivative YX-2102 as a cannabinoid receptor 2 agonist for alleviating lung fibrosis.
Liu T; Gu J; Yuan Y; Yang Q; Zheng PF; Shan C; Wang F; Li H; Xie XQ; Chen XH; Ouyang Q
J Transl Med; 2022 Dec; 20(1):565. PubMed ID: 36474298
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
